Published in Mol Cancer Res on March 09, 2010
Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol (2014) 4.76
Insight into the heterogeneity of breast cancer through next-generation sequencing. J Clin Invest (2011) 1.99
Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. Cancer Discov (2014) 1.77
Circulating tumour cells and cell-free DNA as tools for managing breast cancer. Nat Rev Clin Oncol (2013) 1.33
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. Genome Res (2011) 1.32
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci U S A (2015) 1.18
Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ. Expert Rev Mol Diagn (2013) 0.88
Correlation of histone methyl marks with circulating nucleosomes in blood plasma of cancer patients. Oncol Lett (2012) 0.86
Circulating free DNA in the management of breast cancer. Ann Transl Med (2014) 0.85
Genome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA. PLoS One (2013) 0.84
Cancer detection using whole-genome sequencing of cell free DNA. Oncotarget (2013) 0.84
Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing. Proc Natl Acad Sci U S A (2014) 0.81
Accuracy of Next Generation Sequencing Platforms. Next Gener Seq Appl (2015) 0.80
Cell-free DNA in blood is a potential diagnostic biomarker of breast cancer. Oncol Lett (2012) 0.79
Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis. Oncotarget (2017) 0.75
Profile of the circulating DNA in apparently healthy individuals. Clin Chem (2009) 1.61
Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J Infect Dis (2007) 1.56
Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem (2013) 1.48
The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy. J Am Soc Nephrol (2002) 1.38
Osteogenesis imperfecta in dachshunds. Vet Rec (2013) 1.07
Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study. Clin Chem (2005) 0.97
Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types. Am J Pathol (2009) 0.93
Genome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA. PLoS One (2013) 0.84
Analytical and statistical consideration on the use of the ISAG-ICAR-SNP bovine panel for parentage control, using the Illumina BeadChip technology: example on the German Holstein population. Genet Sel Evol (2015) 0.82
A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. PLoS One (2012) 0.82
Qualitative and quantitative detection of Chlamydophila pneumoniae DNA in cerebrospinal fluid from multiple sclerosis patients and controls. PLoS One (2009) 0.81
Serum DNA motifs predict disease and clinical status in multiple sclerosis. J Mol Diagn (2010) 0.80
Disease-specific motifs can be identified in circulating nucleic acids from live elk and cattle infected with transmissible spongiform encephalopathies. Nucleic Acids Res (2008) 0.79
Early pregnancy diagnosis in dairy cows using circulating nucleic acids. Theriogenology (2012) 0.79
Bov-tA short interspersed nucleotide element sequences in circulating nucleic acids from sera of cattle with bovine spongiform encephalopathy (BSE) and sera of cattle exposed to BSE. Clin Diagn Lab Immunol (2005) 0.79
Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy. Clin Chem (2002) 0.79
[Cellular nucleic acids in serum and plasma as new diagnostic tools]. Berl Munch Tierarztl Wochenschr (2002) 0.78
Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment. Expert Rev Anti Infect Ther (2013) 0.78
Monitoring cyclosporin in blood: between-assay differences at trough and 2 hours post-dose (C2). Ther Drug Monit (2003) 0.78
Monovalent and divalent salt correction algorithms for Tm prediction--recommendations for Primer3 usage. Brief Bioinform (2010) 0.77
Impact of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations in patients with chronic inflammatory diseases. Ann N Y Acad Sci (2006) 0.77
Serum nucleic acids in an experimental bovine transmissible spongiform encephalopathy model. Zoonoses Public Health (2009) 0.77
Design and application of noncontinuously binding probes used for haplotyping and genotyping. Clin Chem (2008) 0.77
Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay. Ther Drug Monit (2010) 0.76
Graft-Derived Cell-Free DNA as a Marker of Transplant Graft Injury. Ther Drug Monit (2016) 0.76
Culture and immunohistochemical evidence of Chlamydia pneumoniae infection in ulcerative pyoderma gangrenosum. J Am Acad Dermatol (2003) 0.75
Chlamydia pneumoniae and acute coronary syndrome. N Engl J Med (2005) 0.75
Analysis of circulating DNA distribution in pregnant and nonpregnant dairy cows. Biol Reprod (2013) 0.75
Graft-derived cell-free DNA as an early organ integrity biomarker after transplantation of a marginal HELLP syndrome donor liver. Transplantation (2014) 0.75
Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation. Ther Drug Monit (2014) 0.75